Form 4: Clover Health Investments, Corp. /De Executive Sells Shares
Insider Transaction (Form 4)
Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 1,921 shares of common stock on September 17, 2026 for $4.56 per share.
Summary
- Open-market sale: disposed of 1,921 Class A Common Stock at $4.56 ($8,760) on September 17, 2026; holds 2,803,446 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $8,760 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jamie L. Reynoso — Officer (CEO, Medicare Advantage)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Open-market sale | Class A Common Stock | 1,921 | $5 | $8.8K | 2,803,446 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Open-market sale (1,921 shares) |
Keywords
insider transaction, Form 4, CLOV, CLOVER HEALTH INVESTMENTS, CORP. /DE, bearish, Jamie L. Reynoso
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.